Join to View Full Profile
1500 E. Medical Center DrD4115 Medical Professional BuildingAnn Arbor, MI 48109
Phone+1 734-615-5707
Fax+1 734-734-6687
Dr. Choi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sung Won Choi, MD, is a Pediatric Hematology & Oncology specialist located in Ann Arbor, MI, with a focus on bone marrow failure syndromes. She completed a fellowship at the University of Michigan in Pediatric Hematology/Oncology from 2002 to 2005, following her medical degree from Wayne State University School of Medicine in 1999, and a Pediatrics residency at NYU Grossman School of Medicine from 1999 to 2002. Dr. Choi has numerous publications on topics including chronic GVHD and immune tolerance after hematopoietic cell transplantation. Her clinical research includes trials on graft versus host disease prophylaxis and health technology monitoring in care settings, where she often serves as Principal Investigator. She has received recognition for her work in electronic medical records, earning CMS Meaningful Use Stage 1 Certifications in 2012 and 2013.
Education & Training
University of MichiganFellowship, Pediatric Hematology/Oncology, 2002 - 2005
NYU Grossman School of MedicineResidency, Pediatrics, 1999 - 2002
Wayne State University School of MedicineClass of 1999
Certifications & Licensure
MI State Medical License 2001 - 2027
OH State Medical License 2005 - 2019
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation Start of enrollment: 2020 Sep 08
- A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients Start of enrollment: 2020 Sep 18
- Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology Start of enrollment: 2020 Apr 28
Publications & Presentations
PubMed
- A digital biomarker dataset from hematopoietic cell transplant caregivers and patients.Aditya Jalin, Nawat Swatthong, Michelle Rozwadowski, Rajnish Kumar, Tom Braun
Scientific Data. 2026-03-27 - "Tough Things You're Going to Have to Go Through": Dyadic Interview Study Including the Perspectives and Needs of Patients and Their Caregivers Post-Hematopoietic Cell...Amanda Johnson, Eleanor Smeallie, Chloe Roslin, Michelle Rozwadowski, Evan Shereck
Journal of Participatory Medicine. 2026-02-19 - 1 citationsDifferential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.Jakob Wirbel, Wael Saber, Michael J Martens, Jonathan U Peled, Tessa M Andermann
Biorxiv. 2026-02-19
Press Mentions
Trouble Sleeping? This Science-Backed App Could Change Your LifeApril 28th, 2025
Grant Support
- BMT Core- University of Michigan Core Clinical Consortium for the BMT Clinical Trials Network (BMT CTN)UNIVERSITY OF MICHIGAN AT ANN ARBOR2001–2031
- BMT Core- University of Michigan Core Clinical Consortium for the BMT Clinical Trials Network (BMT CTN)UNIVERSITY OF MICHIGAN AT ANN ARBOR2001–2031
- Boxer Training Program in HematologyUNIVERSITY OF MICHIGAN AT ANN ARBOR1986–2029
- Boxer Training Program in HematologyUNIVERSITY OF MICHIGAN AT ANN ARBOR1986–2029
- Patient-Oriented Research and Mentoring in Hematopoietic Cell TransplantationUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
